JW (Cayman) Therapeutics Co. Ltd

SEHK:2126 Stock Report

Market Cap: HK$912.4m

JW (Cayman) Therapeutics Management

Management criteria checks 3/4

JW (Cayman) Therapeutics' CEO is James Li, appointed in Feb 2016, has a tenure of 8.25 years. total yearly compensation is CN¥20.98M, comprised of 18.4% salary and 81.6% bonuses, including company stock and options. directly owns 5.15% of the company’s shares, worth HK$46.95M. The average tenure of the management team and the board of directors is 2.3 years and 3.9 years respectively.

Key information

James Li

Chief executive officer


Total compensation

CEO salary percentage18.4%
CEO tenure8.3yrs
CEO ownership5.1%
Management average tenure2.3yrs
Board average tenure3.9yrs

Recent management updates

Recent updates

A Piece Of The Puzzle Missing From JW (Cayman) Therapeutics Co. Ltd's (HKG:2126) 34% Share Price Climb

May 10
A Piece Of The Puzzle Missing From JW (Cayman) Therapeutics Co. Ltd's (HKG:2126) 34% Share Price Climb

Calculating The Intrinsic Value Of JW (Cayman) Therapeutics Co. Ltd (HKG:2126)

May 03
Calculating The Intrinsic Value Of JW (Cayman) Therapeutics Co. Ltd (HKG:2126)

JW (Cayman) Therapeutics Co. Ltd (HKG:2126): When Will It Breakeven?

Feb 03
JW (Cayman) Therapeutics Co. Ltd (HKG:2126): When Will It Breakeven?

CEO Compensation Analysis

How has James Li's remuneration changed compared to JW (Cayman) Therapeutics's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2023CN¥21mCN¥4m


Sep 30 2023n/an/a


Jun 30 2023n/an/a


Mar 31 2023n/an/a


Dec 31 2022CN¥31mCN¥3m


Sep 30 2022n/an/a


Jun 30 2022n/an/a


Mar 31 2022n/an/a


Dec 31 2021CN¥41mCN¥2m


Sep 30 2021n/an/a


Jun 30 2021n/an/a


Mar 31 2021n/an/a


Dec 31 2020CN¥99mCN¥3m


Sep 30 2020n/an/a


Jun 30 2020n/an/a


Mar 31 2020n/an/a


Dec 31 2019CN¥4mCN¥3m


Compensation vs Market: James's total compensation ($USD2.90M) is above average for companies of similar size in the Hong Kong market ($USD232.46K).

Compensation vs Earnings: James's compensation has been consistent with company performance over the past year.


James Li (59 yo)





Dr. Yiping Li, M.D., also known as James, has been a Partner of KPCB China Fund, which is an affiliate of TDF Capital China II, LP, since 2009. He serves as Co-founder and Executive Chairman at JW (Cayman)...

Leadership Team

Yiping Li
CN¥ 47.0m
Cao Xiaoping
Senior Vice President of Tech Operations1.8yrsno datano data
Shaun Paul Cordoba
Senior VP & Chief Scientific Officer2.3yrsno datano data
Raymond J. Hage
Senior Vice President of Corporate Development2.3yrsno datano data
Mark J. Gilbert
Senior Advisor & Acting Chief Medical Officerno datano datano data
Qiang Ma
Senior VP & Chief Commercial Officerno datano datano data
Yun Qin
Senior Vice President of Clinical Sciences & Medical Servicesno datano datano data
Su Yang
Senior Vice President Of Clinical Research & PMOno datano datano data
Ka Man Ng
Company Secretary2.4yrsno datano data


Average Tenure


Average Age

Experienced Management: 2126's management team is considered experienced (2.3 years average tenure).

Board Members

Yiping Li
CN¥ 47.0m
Jiuyun Yu
Independent Non-Executive Director1.2yrsCN¥276.00kno data
Cheng Liu
Non-Executive Director3.9yrsCN¥331.00k1.43%
CN¥ 13.0m
Kin-Cheong Ho
Independent Non-Executive Director3.6yrsCN¥224.00kno data
Sungwon Song
Non-Executive Directorless than a yearno datano data
Yiu Leung Cheung
Independent Non-Executive Director3.6yrsCN¥323.00kno data
Krishnan Viswanadhan
Independent Non-Executive Director4.5yrsCN¥331.00kno data
Xing Gao
Non-Executive Director4yrsno datano data
Ann Li Lee
Independent Non-Executive Director4yrsCN¥331.00kno data


Average Tenure


Average Age

Experienced Board: 2126's board of directors are considered experienced (3.9 years average tenure).

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.